0001213900-23-085753.txt : 20240108 0001213900-23-085753.hdr.sgml : 20240108 20231113112853 ACCESSION NUMBER: 0001213900-23-085753 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 1427702 B.C. Ltd CENTRAL INDEX KEY: 0001988363 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: C/O FASKEN MARTINEAU DUMOULIN LLP STREET 2: 2900 550 BURRARD STEET CITY: VANCOUVER STATE: A1 ZIP: V6C 0A3 BUSINESS PHONE: 6046314952 MAIL ADDRESS: STREET 1: C/O FASKEN MARTINEAU DUMOULIN LLP STREET 2: 2900 550 BURRARD STEET CITY: VANCOUVER STATE: A1 ZIP: V6C 0A3 CORRESP 1 filename1.htm

1427702 B.C. Ltd.

2900-550 Burrard Street

Vancouver, British Columbia, Canada V6C 0A3

November 13, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Attention:	Alan Campbell
	Daniel Crawford
	Mary Mast
	Gary Newberry

Re:	1427702 B.C. Ltd.
	Registration Statement on Form F-4
	Filed on August 14, 2023, as amended
	File No. 333-273972

To the addressees set forth above:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, 1427702 B.C. Ltd. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. ET on November 13, 2023, or as soon as thereafter practicable.

	Very truly yours,

	/s/ Ryan Wilson
	Ryan Wilson
	Director

cc: Ellenoff Grossman & Schole LLP